English | Español
Nicholas Gueguen | Aug 1, 2017

Aeolus Pharmaceuticals starts Phase 1 test of radiation exposure treatment
Nicholas Gueguen | Aug 1, 2017

MedImmune, Sanofi Pasteur to create and market respiratory tract illness prevention drug

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’